Identification, cloning and characterization of SpEX exotoxin produced by Staphylococcus pseudintermedius

Area of Science:

• Veterinary Microbiology
• Immunology
• Molecular Biology

Background:

• Staphylococci employ immune evasion strategies, including toxins targeting innate immunity.
• Staphylococcus pseudintermedius is an important pathogen in companion animals.
• Understanding virulence factors is crucial for developing effective treatments and vaccines.

Purpose of the Study:

• To identify and characterize a novel exotoxin (SpEX) from Staphylococcus pseudintermedius.
• To investigate the role of SpEX in immune evasion and virulence.
• To evaluate the potential of SpEX as a vaccine candidate.

Main Methods:

• Secretome analysis using liquid chromatography-mass spectrometry and genomic data.
• Predictive modeling for protein structure and function.
• In vitro assays to assess SpEX cytotoxicity, complement interaction, and immune cell effects.
• Generation and testing of a mutant SpEX and anti-SpEX antibodies.

Main Results:

• SpEX identified as a novel exotoxin with structural similarity to staphylococcal superantigen-like proteins.
• SpEX binds complement component C5 and inhibits complement-mediated lysis.
• SpEX exhibits cytotoxicity towards leukocytes and inhibits neutrophil migration.
• Mutant SpEX shows reduced cytotoxicity, and anti-SpEX antibodies mitigate SpEX effects.

Conclusions:

• SpEX is a significant virulence factor for Staphylococcus pseudintermedius, contributing to immune evasion.
• Targeting SpEX may be a viable strategy for controlling S. pseudintermedius infections.
• Attenuated SpEX represents a promising candidate for vaccine development against S. pseudintermedius.